QC
VCYT icon

Quadrature Capital’s Veracyte VCYT Stock Holding History

Quadrature Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754K Buy
12,837
+5,243
+69% +$220K 0.01% 837
2026
Q1 		$245K Buy
+7,594
New +$281K ﹤0.01% 1052

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quadrature Capital's VCYT Position: Q2 2026 in Review

Quadrature Capital increased its Veracyte (VCYT) stake by 69% in Q2 2026, buying an estimated $220K and bringing the position to 12,837 shares worth $754K. The position accounts for 0.01% of the portfolio, ranked #837.

Quadrature Capital first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Quadrature Capital held 12,837 shares of Veracyte worth $754K as of Q2 2026.
  • Quadrature Capital bought 5,243 Veracyte shares in Q2 2026, an estimated $220K.
  • Veracyte made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #837 holding.
  • Quadrature Capital first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.